Welcome to the MGH FTD Unit
The MGH Frontotemporal Disorders (FTD) Unit has at its core a 
multidisciplinary clinic in which comprehensive evaluations are performed 
for the purposes of diagnosis, treatment, and monitoring. 
The evaluation typically involves a neurologic assessment, neuropsychologic 
assessment, speech and language assessment, and potentially additional 
assessments by neuropsychiatry and social work. There are often tests 
ordered as well as brain scans and similar procedures. The evaluation is 
tailored to the individual, but many of these components are performed 
with each person.
Typically, one or more persons who know the patient well are interviewed in 
detail to find out more about the symptoms that are present in daily life. 
This is often done initially as a telephone intake and subsequently in 
person during one or more visits.
At the clinic evaluation, a behavioral neurology/neuropsychiatry fellow 
(a 
neurologist or psychiatrist in advanced training focusing on dementia and related conditions) 
will obtain the history in detail, performan an examination of the patient, review records, and 
together with one of our faculty neurologists will 
make recommendations for further evaluation if necessary. For many patients, a speech-language 
pathologist or trainee will also evaluate the patient and/or interview the care partner. A member 
of our care partner support team will meet with the family member(s) or other care partner(s).
The various specialists who perform the evaluations then will discuss the 
results together as a team and try to come to a consensus regarding the 
diagnosis, and will also make recommendations for treatment, management, 
planning, and monitoring.
Ongoing care can then be coordinated by the MGH FTD Unit or in conjunction 
with specialists who have already been working with the patient.
To inquire about an appointment, email us at MGHFTDUnit@mgh.harvard.edu or 
call 617-726-1728.
 
 The MGH FTD Unit aims to develop better 
knowledge about and diagnosis and treatment of all forms of FTD and 
related focal dementia syndromes. The PPA Program aims to better 
understand and treat primary progressive aphasia syndromes using existing 
technologies (including speech therapy) and by developing new diagnostic 
and treatment technologies.											 
											 
To obtain medical records, please follow the directions below:
 
            